rs141373204

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001875.5(CPS1):​c.3643A>G​(p.Ile1215Val) variant causes a missense change. The variant allele was found at a frequency of 0.00112 in 1,611,068 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 2 hom., cov: 28)
Exomes 𝑓: 0.0011 ( 9 hom. )

Consequence

CPS1
NM_001875.5 missense

Scores

2
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:11B:2

Conservation

PhyloP100: 5.82

Publications

13 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0088790655).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00126 (188/149678) while in subpopulation AMR AF = 0.00235 (35/14884). AF 95% confidence interval is 0.00174. There are 2 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 28. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.3643A>Gp.Ile1215Val
missense
Exon 30 of 38NP_001866.2
CPS1
NM_001369256.1
c.3676A>Gp.Ile1226Val
missense
Exon 31 of 39NP_001356185.1
CPS1
NM_001122633.3
c.3643A>Gp.Ile1215Val
missense
Exon 31 of 39NP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.3643A>Gp.Ile1215Val
missense
Exon 30 of 38ENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.3661A>Gp.Ile1221Val
missense
Exon 31 of 39ENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2290A>Gp.Ile764Val
missense
Exon 20 of 28ENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.00126
AC:
188
AN:
149584
Hom.:
2
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.000124
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00235
Gnomad ASJ
AF:
0.0171
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00169
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0292
Gnomad NFE
AF:
0.000944
Gnomad OTH
AF:
0.00391
GnomAD2 exomes
AF:
0.00159
AC:
401
AN:
251480
AF XY:
0.00160
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.0157
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00117
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00110
AC:
1610
AN:
1461390
Hom.:
9
Cov.:
35
AF XY:
0.00115
AC XY:
838
AN XY:
727046
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33476
American (AMR)
AF:
0.00170
AC:
76
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0147
AC:
384
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000638
AC:
55
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.0111
AC:
64
AN:
5768
European-Non Finnish (NFE)
AF:
0.000761
AC:
846
AN:
1111546
Other (OTH)
AF:
0.00295
AC:
178
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
78
156
235
313
391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00126
AC:
188
AN:
149678
Hom.:
2
Cov.:
28
AF XY:
0.00113
AC XY:
82
AN XY:
72814
show subpopulations
African (AFR)
AF:
0.000123
AC:
5
AN:
40570
American (AMR)
AF:
0.00235
AC:
35
AN:
14884
Ashkenazi Jewish (ASJ)
AF:
0.0171
AC:
59
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5092
South Asian (SAS)
AF:
0.00170
AC:
8
AN:
4718
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9942
Middle Eastern (MID)
AF:
0.0315
AC:
9
AN:
286
European-Non Finnish (NFE)
AF:
0.000945
AC:
64
AN:
67756
Other (OTH)
AF:
0.00388
AC:
8
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00173
Hom.:
3
Bravo
AF:
0.00131
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00140
AC:
12
ExAC
AF:
0.00150
AC:
182
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00196
EpiControl
AF:
0.00255

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
5
2
Congenital hyperammonemia, type I (7)
-
4
-
not provided (4)
-
1
-
not specified (1)
-
1
-
Pulmonary hypertension, neonatal, susceptibility to;C4082171:Congenital hyperammonemia, type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.016
T
BayesDel_noAF
Pathogenic
0.19
CADD
Benign
17
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.67
D
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.0089
T
MetaSVM
Uncertain
0.73
D
MutationAssessor
Benign
1.3
L
PhyloP100
5.8
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-0.81
N
REVEL
Pathogenic
0.70
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.017
D
Polyphen
0.62
P
Vest4
0.28
MVP
0.85
MPC
0.20
ClinPred
0.018
T
GERP RS
4.9
Varity_R
0.58
gMVP
0.71
Mutation Taster
=66/34
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141373204; hg19: chr2-211521333; COSMIC: COSV51822452; COSMIC: COSV51822452; API